Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 1:43 PM ET

Biotechnology

Company Overview of Stemina Biomarker Discovery, Inc.

Company Overview

Stemina Biomarker Discovery, Inc., a metabolomics company, focuses on the discovery, development, and commercialization of molecular biomarkers to improve drug safety and human health. The company works on collaborative research projects and joint development agreements with strategic partners to develop drugs, identify targets, and discover molecular biomarkers for the diagnosis of diseases and customized treatment. It provides metabolomics and mass spectrometry services, as well as develops diagnostic biomarkers. The company’s cell-based assays arise from the strategic convergence of technologies, such as human embryonic stem (hES) cells and metabolomics. It uses mass spectrometry to analy...

504 South Rosa Road

Suite 150

Madison, WI 53719

United States

Founded in 2006

Phone:

608-204-0104

Fax:

608-204-0107

Key Executives for Stemina Biomarker Discovery, Inc.

Chief Executive Officer and Director
Director of BioAnalytical Chemistry
Senior Scientist of BioAnalytical Chemistry
Compensation as of Fiscal Year 2015.

Stemina Biomarker Discovery, Inc. Key Developments

Stemina Presents at 2014 Autism Investment Conference, Mar-04-2014 09:00 AM

Stemina Presents at 2014 Autism Investment Conference, Mar-04-2014 09:00 AM. Venue: Bently Reserve, 301 Battery St, San Francisco, CA 94111, United States. Speakers: Marc Schneebaum, Head of Stemina Diagnostics.

Stemina Biomarker Receives Contract to Test for Toxins from U.S. Environmental Protection Agency

Stemina Biomarker has won a five-year, $10.6 million contract for its devTOX technology from the U.S. Environmental Protection Agency.

Stemina Biomarker Discovery, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 01:30 PM

Stemina Biomarker Discovery, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 01:30 PM. Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
Lypro Biosciences, Inc. United States
Adult Stem Cell Corporation of America, Inc. United States
Leidos Biomedical Research, Inc. United States
CDG Therapeutics, Inc. United States
Immunotope, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 31, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Stemina Biomarker Discovery, Inc., please visit www.stemina.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.